Is There a Once-a-Day Weight Loss Injection?

Why you won't find a once-daily weight loss injection on a UK prescription

The question is completely understandable. 'Once a day' is the rhythm most people associate with medication, a tablet at breakfast, a drop at night. Injections feel like they should follow the same logic. They don't, and the reason is pharmacology.

Tirzepatide and semaglutide are both designed as long-acting molecules. Tirzepatide, the active ingredient in Mounjaro, has a half-life of around five days in the body, which is why a single weekly injection maintains a stable level of the medicine throughout the week. Semaglutide, in Wegovy, works similarly. Injecting either medicine daily would not improve results and would significantly increase the burden on patients, and the risk of injection-site reactions. The NHS medicines page for tirzepatide confirms the once-weekly schedule as standard.

There are historical precedents for daily weight-related injections (liraglutide (Saxenda) required a daily injection) but that medicine is not dispensed by nume, and it has largely been superseded in clinical practice by the more effective once-a-week injections for weight loss, which are now the standard choice for UK prescribers. For now, if a UK prescriber writes you a weight-loss injection prescription, it will be a weekly one.

The one genuine 'daily' option: what the new oral tablet actually involves

Here is where 'once a day' does apply, just not to an injection. In June 2026, the MHRA approved the Wegovy tablet (oral semaglutide) as the first oral GLP-1 medicine licensed in the UK for weight management, making the UK the first in Europe to grant this approval. It is taken once daily, first thing in the morning, on an empty stomach with a small amount of plain water. You wait at least thirty minutes before eating, drinking anything other than water, or taking other oral medicines.

The dosing ladder starts at 1.5 mg and works up through 4 mg and 9 mg to a 25 mg maintenance dose, with at least a month at each level. In the OASIS 4 phase-3 trial (307 adults, 64 weeks), participants lost an average of around 13.6% of their body weight compared with around 2.4% on placebo. Among those who stayed fully adherent to treatment, the average was closer to 17%, though that figure applies specifically to the adherent subgroup, not to the trial population overall.

For people who prefer not to inject, this is a meaningful shift. It's also worth knowing that if you're already established on the 2.4 mg weekly injection, moving to the 25 mg tablet is something a prescriber can discuss with you as an option, subject to clinical assessment. You can read more about how licensed weight-loss injections compare to help put the tablet option in context.

The decision: injection once a week, or tablet once a day?

This is genuinely the decision many people are now facing, and it's worth thinking through the practical factors before a consultation.

Weekly injections have a longer track record. Tirzepatide's SURMOUNT programme involved thousands of adults, and the published trial data (including the SURMOUNT-5 head-to-head published in the New England Journal of Medicine (2025)) shows greater average weight reduction with tirzepatide than with semaglutide 2.4 mg. Wegovy injection data at 2.4 mg showed roughly 15% average body-weight reduction over 68 weeks in the STEP 1 trial.

For the daily tablet, the routine suits some people better. No needles, no sharps disposal, no refrigeration, the blister pack sits on the kitchen counter, taken before the kettle boils. Travel is simpler. The trade-off is the morning window: you need to plan around that thirty-minute wait, every day, without exception, because food or drink within that window reduces absorption significantly.

Neither option is universally 'better'. Both are prescription-only, and both require a prescriber to weigh up your health history, current medicines, and preferences. If you are considering a weight loss injection in the stomach once a week, that remains the most prescribed route; the tablet is newer but MHRA-approved and available now. If you're curious about the cost side of these options, our weight-loss injection cost page sets out what private treatment pricing actually includes.

What a prescriber looks at before recommending either

Eligibility for licensed weight-loss medicines isn't simply a BMI check. The SmPCs for both Mounjaro and Wegovy set out private eligibility as adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, prediabetes or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone, however, doesn't settle the question.

A prescriber also considers whether you have any conditions that would make these medicines unsuitable, certain gastrointestinal disorders, a personal or family history of medullary thyroid carcinoma, or a history of pancreatitis, for instance. Current medicines matter too: tirzepatide can reduce the absorption of oral medicines taken at the same time, which has implications for anyone on the oral contraceptive pill (additional contraception is recommended for the first four weeks of treatment and after each dose increase). Our clinical team reviews every consultation personally before any prescription is issued.

The MHRA has also reminded prescribers and patients that these medicines are not assessed for quick or cosmetic weight loss, they are indicated for weight management in adults meeting specific clinical criteria, used alongside a reduced-calorie diet and increased physical activity. Patients exploring a once a month weight loss injection should be aware that no such schedule is currently licensed in the UK, which is a useful point to clarify before starting any consultation. If you are based locally, you can also find out more about weight loss injections in Doncaster, where our service is available to eligible patients. If you'd like to understand the broader treatment options for weight loss before making any decision, that's a sensible starting point. When you're ready to discuss your own situation with a prescriber, you can start a free consultation with our team.